Greg Brophy: Chief Executive Officer
Mr. Brophy has served in a number of diverse operating roles including executive officer roles in two public companies (NYSE & NASDAQ), president of four distinct business groups, and head of business development with significant M&A and corporate finance experience. Operating roles have been in the medical device, biomedical, and healthcare services sectors, with experience ranging from a dynamic high growth environment to division turnaround responsibilities in connection with the break up of a public company. Mr. Brophy holds a BS in Electrical Engineering from the University of Notre Dame, a JD from the University of Georgia School of Law, and an MBA from the MIT Sloan School of Management.
John Joyoprayitno: Chief Operating Officer, Co-founder
Mr. Joyoprayitno oversees general operations, business development, sales, and distribution. Mr. Joyoprayitno has over 15 years of entrepreneurial experience founding, launching, growing, and managing companies ranging from medical, distribution, automotive, to consulting (medical, utility, technology, recreation). Mr. Joyoprayitno earned an MS in Technology Commercialization from the McCombs School of Business at The University of Texas at Austin.
Sarah Mayes, PhD, RAC: Chief of Clinical Affairs, Co-founder
Dr. Mayes is a co-inventor of the Alafair technology. Dr. Mayes oversees pre-clinical, clinical, pipeline product development, and regulatory activities. Dr. Mayes earned a PhD in biomedical engineering from The University of Texas at Austin. She earned an MS in material science & engineering from The University of Michigan, Ann Arbor.
Ben Walthall, PhD: Chief Regulatory Officer
Dr. Walthall brings over 30 years of varied experience in new technology and product development. He is the author of numerous peer-reviewed articles and holds several patents in the biomedical field. Prior to joining Alafair, Dr. Walthall served as VP of R&D for Zimmer Biologics where he was responsible for directing biologic and drug delivery R&D in areas such as bone healing, spinal disc regeneration, restoration of soft tissue function, and cartilage repair. He has previously held senior positions in a variety of medical device companies managing technology strategies, portfolio management, and PD. Dr. Walthall earned a PhD in biochemistry from The University of Texas at Austin.
Daniel Peterson, MD: Medical Director, Chairman
Dr. Peterson is a neurosurgeon and an adjunct professor in biomedical engineering at The University of Texas at Austin. He received his MD from University of Colorado Health Science Center School of Medicine, and completed both internship and residency at The University of Texas Health Science Center at San Antonio. Dr. Peterson has consulted for Stryker Spine, Osteomed Spine, and Orthokinematics, and was the Austin PI in a phase III clinical trial using LDR Spine's Mobi-C artificial cervical disc.
Bhushan Holay: VP of Finance
Mr. Holay has worked in the medical device industry for over a decade, with experience in research, product development, project management, and marketing. Prior to Alafair, he led the product development and commercialization efforts at Zimmer, Inc developing several commercially available implant biologics. Mr. Holay earned an MBA from The McCombs School of Business at The University of Texas at Austin and an MS in Chemical Engineering from Syracuse University.